Journal article
Letter: Incidence and Predictors of Major Gastrointestinal Bleeding in Patients on Aspirin, Low‐Dose Rivaroxaban or the Combination: Secondary Analysis of the COMPASS Randomised Controlled Trial. Authors' Reply
Authors
Forbes N; Bosch J; Eikelboom JW
Journal
Alimentary Pharmacology & Therapeutics, Vol. 60, No. 11-12, pp. 1652–1653
Publisher
Wiley
Publication Date
December 1, 2024
DOI
10.1111/apt.18317
ISSN
0269-2813